Month: December 2019
NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Dec. 31, 2019 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (“ProMIS” or the “Company”) (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases is pleased to announce that further to its news releases dated November 13, 2019 and November 18, 2019, it completed, on December 31, 2019 the second closing of its private placement. In the second closing, the Company issued 3,724,998 units (each a “Unit”) for gross proceeds of approximately CDN$745,000. The total gross proceeds raised to date under the private placement are $2,800,333.In connection with...
WSP Strengthens Its Expertise in Environment in the US With the Closing of the E & E Transaction
Written by Customer Service on . Posted in Public Companies.
MONTREAL, Dec. 31, 2019 (GLOBE NEWSWIRE) — WSP Global Inc. (TSX: WSP) (“WSP” or the “Corporation”) today announced that, following the receipt of the required regulatory approvals and the satisfaction of the conditions to the merger agreement, it has completed its previously announced acquisition of Ecology and Environment Inc. (NASDAQ: EEI) (“E & E”), a US-headquartered environmental consulting firm which provides professional services to governments and private customers worldwide.The purchase price payable in connection with the acquisition was approximately $US 65 million, plus a special dividend of approximately $US 2.2 million. It was paid in cash and was financed using WSP’s available cash and credit facilities.“I am pleased with this transaction which brings together complementary...
WSP renforce son expertise en environnement aux États-Unis avec la clôture de la transaction visant E & E
Written by Customer Service on . Posted in Public Companies.
MONTREAL, 31 déc. 2019 (GLOBE NEWSWIRE) — Groupe WSP Global Inc. (TSX : WSP) (« WSP » ou la « Société ») a annoncé aujourd’hui que, suite à la réception des approbations réglementaires requises et la satisfaction des conditions de l’entente de fusion, elle a conclu l’acquisition d’Ecology and Environment Inc. (NASDAQ : EEI) (« E & E »), communiquée précédemment. Société de conseil en environnement dont le siège social est situé aux États-Unis, E & E fournit des services professionnels aux gouvernements et aux clients du secteur privé à travers le monde.Le prix d’achat à payer dans le cadre de l’acquisition...
Pineapple Express Announces Rebranding to Pineapple Inc. Updates Shareholders on Plans to Upgrade to OTCQB
Written by Customer Service on . Posted in Public Companies.
Company takes further steps to become current with the SEC and files to rebrand as Pineapple, Inc.; Anticipates beginning to receive revenues from portfolio asset Pineapple Ventures, Inc. in 2020LOS ANGELES, Dec. 31, 2019 (GLOBE NEWSWIRE) — PINEAPPLE EXPRESS, INC. (OTC Grey: PNPL) (the “Company” or “Pineapple Express”), a publicly traded company in the legal cannabis industry that through its portfolio of assets offers operational management, technology, capital, IP licensing, and turn-key property rentals, today announced that it anticipates filing its annual report for the fiscal year ended December 31, 2018 with the United States Securities and Exchange Commission in January of 2020. The Company’s management anticipates filing the requisite reports shortly...
RESEARCH FRONTIERS’ SPD-SMARTGLASS LICENSED TO GLATIC TO PRODUCE SPD-SMART WINDOWS FOR THE SOUTH KOREAN ARCHITECTURAL MARKET
Written by Customer Service on . Posted in Public Companies.
Woodbury, New York and Seoul, Korea, Dec. 31, 2019 (GLOBE NEWSWIRE) — Research Frontiers (Nasdaq: REFR) and Glatic Co., Ltd. jointly announced today that Glatic has acquired a license from Research Frontiers Inc. to produce and sell SPD-SmartGlass smart windows for the South Korean architectural market.SPD-Smart light control film, invented and patented by Research Frontiers, is a key component in SPD-SmartGlass products. This film allows users to instantly, precisely and uniformly control the shading of glass or plastic products, either manually or automatically at the touch of a button. Products using Research Frontiers’ smart glass technology are being used in tens of thousands of cars, aircraft, yachts, trains, homes, offices, museums and other buildings.Eun-sik Park, CEO of Glatic, noted: “Glatic’s mission...
Agreement signed with the Icelandic Aircraft Mechanics Association (FVFI)
Written by Customer Service on . Posted in Public Companies.
Icelandair ehf. and the Icelandic Aircraft Mechanics Association (FVFI) have renewed their current collective-bargaining agreement until 31 December 2020. The salary increases in the collective-bargaining agreement are in line with other agreements made between labor unions and employer federations in 2019 (Icelandic: Lífskjarasamningar). FVFI will now present the collective-bargaining agreement to its members who will vote on the agreement.Contact informationInvestors: Íris Hulda Þórisdóttir, Director Investor Relations. E-mail: iris@icelandairgroup.isMedia: Ásdís Pétursdóttir, Director Communications. E-mail: asdis@icelandair.is
Total number of shares and voting rights in Zealand Pharma at December 31, 2019
Written by Customer Service on . Posted in Public Companies.
Company announcement – No. 49 / 2019Total number of shares and voting rights in Zealand Pharma at December 31, 2019Copenhagen, December 31, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with Section 10 of the Danish Statutory Order on Issuers’ Disclosure Obligations, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital. In Company announcement No. 47/2019, Zealand announced an increase in share capital relating to the exercise of employee warrants. Following this announcement, the table below lists the total number of shares and voting...
LINEDATA SERVICES :Réduction du capital social par annulation de 554 996 actions propres représentant 7,7% du capital
Written by Customer Service on . Posted in Public Companies.
Réduction du capital social par annulation de 554 996 actions propres représentant 7,7% du capitalNeuilly-sur-Seine, le 31 décembre 2019 – Linedata (LIN:FP), éditeur de solutions globales et prestataire de services d’outsourcing pour les professionnels de l’asset management, de l’assurance et du crédit, annonce que dans sa séance du 10 décembre 2019, le Conseil d’Administration, faisant usage des pouvoirs conférés par l’Assemblée Générale Mixte du 21 mai 2019 et après obtention de la dérogation à l’obligation de déposer un projet d’offre publique visant les actions de la société auprès de l’Autorité des Marchés Financiers,...
Century Metals Inc. Provides Update on Its Acquisition of Reyna Silver Corp.
Written by Customer Service on . Posted in Public Companies.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES.TORONTO, Dec. 31, 2019 (GLOBE NEWSWIRE) — Century Metals Inc. (“Century Metals” or the “Company”) (TSXV: CMET). Further to the Company’s news release of September 24, 2019, the Company provides the following update on its proposed acquisition (the “Acquisition”) of all the issued and outstanding share capital of Reyna Silver Corp. (“Reyna Silver”). Acquisition TermsIn conjunction with the Acquisition:(i) Century Metals will eliminate all of its current and long-term liabilities by paying the same in cash or issuing Century Metals common shares in settlement thereof;(ii) Century Metals will then consolidate its outstanding common shares (the “Century Consolidated...
Onconova Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-The-Market
Written by Customer Service on . Posted in Public Companies.
NEWTOWN, Pa., Dec. 31, 2019 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova” or the “Company”), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that it has entered into definitive agreements with [two] healthcare-focused institutional investors for the issuance and sale in a registered direct offering of 27,662,518 shares of its common stock at a purchase price of $0.3615 per share, for aggregate gross proceeds of approximately $10 million in a registered direct offering priced at-the-market under Nasdaq rules.H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.The offering is expected to close on or about January 3, 2019,...